AGER and lung adenocarcinoma: Pathway-based signatures of the HMGB1 / RAGE signalling pathway, the beta-adrenergic receptor regulation of the ERK pathway and the clathrin-coated vesicle cycle pathway are significantly associated with clinical outcome of lung adenocarcinoma